The Venture Codex Logo

The Venture Codex

Mivtach Shamir

HaBarzel 27, Tel Aviv, 6971039, Israel

Overview

Mivtach Shamir Holdings is a publicly-traded Israeli investment company headed by owner and CEO Meir Shamir. It holds a diverse portfolio of lucrative international assets, investing primarily in commercial real estate, startups, and tangibles. Corporate History Mivtach Shamir’s roots extend back to December 1958. At that time, there was a company named Attas Industries Halva, Tahini, and Sweets. Attas was a small private company that was in the business of producing confectionaries and luxury foods. In 1983, Attas Industries was listed on the Tel Aviv Stock Exchange and became a public company for the first time. Approximately 10 years later, Attas Industries caught the eye of Meir Shamir a savvy businessman who purchased the company. At this time, Attas Industries began its transition from food production to pension fund management and insurance. Its name was changed to Mivtach Shamir Insurance Agency. But, this was only the beginning. The following year, Attas Industries became Mivtach Shamir Holdings, Ltd, with a refocused mission and new portfolio of assets. Mivtach Shamir Investments Mivtach Shamir Holdings has concluded a number of notable investments. Among them are: Technology: Mivtach Shamir purchased a 10% share in Zen Media, an internet company in 1999. Zen Media was well known for its very popular site—Tapuz People. Mivtach sold 55.1% of its stock to Migdal Group in 2001. It earned approximately $19 million on the sale. Food Production: In partnership with iFix, Mivtach Shamir purchased Tnuva Group in 2008. Tnuva is a well-known Israeli food production company. Mivtach sold its shared in Tnuva in March 2015 to the Chinese affiliate of Brightfood. The sale was concluded for €252 million. Pharmaceuticals: Mivtach Shamir currently owns 26.75% of the capital and voting rights in Vidac Pharma. It invested in the company in 2014, infusing NIS 19 million into Vidac. Vidac Pharma is a biopharma company currently focused on developing ground-breaking treatments for skin cancer. Corporate Social Responsibility A cornerstone of Mivtach Shamir’s strategic plan is focused on corporate social responsibility. The importance of giving back is embedded deeply in CEO Meir Shamir and the company’s staff. To this end, the Mivtach Shamir is involved in a number of charitable projects throughout Israel. Its signature projects are ZAKA and the IDF Adopt-a-Soldier project. The Adopt-a-Soldier program is a unique Israeli project that provides a full support basket to soldiers serving in the IDF without family. The majority of lone soldiers are from abroad but include Israelis too. Mivtach Shamir has partnered with the Ametz Loham (adopt a soldier) project under the auspices of the Wellbeing of Israel’s Soldiers (AWIS). Through the Adopt-a-Soldier program, individuals and business are able to donate supplies, money, and mentorship to these special soldiers. Mivtach Shamir has adopted the 69 "Hammers" Air Force Squadron, the unit in which Meir Shamir served when he was in the IDF in the 1970s. The second signature project is ZAKA, a volunteer-based network of emergency response teams who respond daily to life-threatening calls. ZAKA is often the first to appear on the scene, providing on-site emergency treatment and crisis intervention. Among their additional duties are identifying disaster and terrorism victims, interacting and assisting on-the-ground ambulance crews and medical staff, and community outreach. Mivtach Shamir is happy to have been able to donate a special ambulance to ZAKA. The ambulance was donated in 2015 to the Petah Tikva ZAKA team. It is specially equipped to meet the unique needs of the ZAKA team.

Total investments
3
Lead investments
0
Investments · 12mo
0
Active investors
0

Sector focus

  • Venture Capital
Visit website

Investment portfolio

  • StreamElements

    Participated · Equity · Sep 2021

    StreamElements offers free creator tools focused on livestreaming and video-on-demand, including production, community engagement and analytics features. Its platform is used by 1.1 million creators and reported usage growth of 233%, with over 60% of top creators (20,000+ views/followers) using its dashboard. The company’s primary revenue comes from brand partnerships and influencer-driven sponsorship activations powered by its proprietary measurement technology. With the new funding it plans to expand on-demand features, build presence on additional platforms such as Trovo, and invest in marketing to attract more creators globally. The company is Tel Aviv/Los Angeles-based and announced a leadership reshuffle alongside its growth plans, with co-founder Gil Hirsch taking the CEO role. StreamElements provides a full production-technology and business stack for live-stream production, monetization and audience engagement, with customer support. Founded in 2017 and based in Palo Alto and Tel Aviv, the company serves professional creators and streamers. Its platform supports over 200K monthly-active channels across Twitch and YouTube, reaches more than 15 million viewers and accumulates over 12 billion minutes watched each month. Top streamers such as Shroud, TimTheTatMan, SodaPoppin and Casey Neistat use the platform. The company and its creator community have partnered on marketing campaigns with brands including Red Bull, Sennheiser, Warner Brothers, Trojan and 7-11. StreamElements plans to use new funding to expand product features, increase platform adoption and grow its global Brand Partnership team.

  • Lendbuzz

    Participated · Series C · Jun 2021

    Founded in 2015 and headquartered in Boston, Massachusetts, Lendbuzz leverages artificial intelligence and machine learning to evaluate non-traditional data and extend vehicle loans to borrowers who are often overlooked by conventional credit models. Its platform processes large data sets to more accurately predict a consumer’s credit profile, benefiting both consumers—through expanded credit access—and auto dealerships via increased sales. Since launching its asset-backed securitization (ABS) program in late 2021, the company has completed more than $2.4 billion of publicly syndicated ABS transactions across eleven deals, providing diversified funding for continued loan origination. Lendbuzz structures these securitizations around pools of loans secured by new and used cars, light trucks, and vans. The firm’s growing investor interest underscores market confidence in its underwriting technology and loan performance. By expanding its capital base through repeated ABS issuance, Lendbuzz aims to scale its mission of fair credit access for millions of potential car buyers.

  • Vidac Pharma

    Participated · Series A · Jun 2016

    Vidac Pharma is a clinical-stage pharmaceutical company focused on discovering and developing first-in-class small-molecule therapies for oncologic and oncodermatologic diseases. Its lead product, VDA-1102, is a topical ointment that completed Phase 1 and is currently in a Phase 2 clinical trial for actinic keratosis. The company’s technology targets the cancer-specific VDAC/HK2 system to induce selective apoptosis of malignant cells while sparing healthy tissue. Vidac plans to use the new financing to advance VDA-1102 through clinical development and to progress its broader pipeline into clinical studies. The company emphasizes translating breakthroughs in mitochondria and cancer metabolism into therapies that are both efficacious and well tolerated. Financially, Vidac has just closed a financing to support these clinical and development plans.

Team

No current team members are available.